Barclays Maintains Overweight on Encompass Health, Raises Price Target to $116
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok has maintained an Overweight rating on Encompass Health (NYSE:EHC) and raised the price target from $109 to $116.
October 29, 2024 | 12:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays has maintained an Overweight rating on Encompass Health and increased the price target from $109 to $116, indicating a positive outlook.
The increase in price target from $109 to $116 by Barclays suggests a positive outlook for Encompass Health, likely leading to a short-term increase in stock price. The Overweight rating indicates confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100